Get started
Work

Phase I Analysis of DOC1021, A Cell-based Vaccination Platform for Adjuvant Therapy of Glioblastoma (S29.004)

Year: 2025
Type: article
Study design: Clinical Trial
Source: Neurology
DOI: 10.1212/wnl.0000000000211043
Authors: Jay-Jiguang Zhu, Yoshua Esquenazi, Sigmund Hsu, Rodrick Zvavanjanja, Mia Vu, Eva Schumann, Akshar Trivedi, Wei Liu, Madhuri Shailesh Namekar, Colby James Hofferek, Keenan James Ernste, Corey Mossop, Christina Clay, Sabina Amin, Vinod Ravi, Jan Kemnade, Laura Aguilar, Alan Turtz, Nitin Tandon, Vanaja Konduri, Joseph Georges, William Decker
Institutions: The University of Texas Health Science Center at Houston, Baylor College of Medicine, Cooper University Health Care, The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, UAB Medicine, Banner Health, Banner - University Medical Center Tucson
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409227302
FWCI: 0.541
Cites:
Cited by: 1
Related to: 10